Mazdutide Consolidates Potential Efficacy Lead In China GLP-1 Obesity Race

 
• By Dexter Jie Yan
  
China obesity market
$5.5bn domestic market predicted for 2030 enticing Chinese developers of obesity drugs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Archive

More from Scrip